Mustang Bio received a notice from Nasdaq indicating that its common stock price has closed below $1.00 per share for 31 consecutive business days, and the company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company has a grace period until November 12, 2024, to regain compliance.